Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models

Journal of Controlled Release

Volumn 172, Issue 1, 2013, Pages 86-95

  Godugu, Chandraiah ^a   Patel, Apurva R ^a   Doddapaneni, Ravi ^a   Marepally, Srujan ^a   Jackson, Tanise ^a   Singh, Mandip ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Collagen; Distribution; Inhalation; Intratumoral; Nanotherapeutics; Telmisartan

Indexed keywords

ANIMALS; BIOLOGICAL ORGANS; COLLAGEN; DISEASES; ENZYME INHIBITION; FLUORESCENCE; TUMORS;

DISTRIBUTION; INHALATION; INTRATUMORAL; NANOTHERAPEUTICS; TELMISARTAN;

NANOPARTICLES;

CASPASE 3; COLLAGEN TYPE 1; LOSARTAN; MA 01835; NANOPARTICLE; TELMISARTAN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CAPILLARY DENSITY; CHEMICAL INDUSTRY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; FEMALE; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TUMOR VOLUME; WESTERN BLOTTING;

COLLAGEN; INHALATION; INTRATUMORAL DISTRIBUTION; NANOTHERAPEUTICS; TELMISARTAN;

ADMINISTRATION, INHALATION; ANIMALS; ANTINEOPLASTIC AGENTS; BENZIMIDAZOLES; BENZOATES; CELL LINE, TUMOR; COLLAGEN; FEMALE; HUMANS; LOSARTAN; LUNG; LUNG NEOPLASMS; MICE; NANOPARTICLES;

EID: 84884306434     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.06.036s     Document Type: Article

References (52)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J. Clin. 62 2012 10 29
2. J.R. Molina, P. Yang, S.D. Cassivi, S.E. Schild, and A.A. Adjei Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship Mayo Clin. Proc. 83 2008 584 594 (Pubitemid 351720831)
3. R. Califano, A.Z. Abidin, R. Peck, C. Faivre-Finn, and P. Lorigan Management of small cell lung cancer: recent developments for optimal care Drugs 72 2012 471 490
4. K. Kim, J.H. Kim, H. Park, Y.S. Kim, K. Park, H. Nam, S. Lee, J.H. Park, R.W. Park, I.S. Kim, K. Choi, S.Y. Kim, and I.C. Kwon Tumor-homing multifunctional nanoparticles for cancer theragnosis: simultaneous diagnosis, drug delivery, and therapeutic monitoring J. Control. Release 146 2010 219 227
5. S. Sandhiya, S.A. Dkhar, and A. Surendiran Emerging trends of nanomedicine - an overview Fundam. Clin. Pharmacol. 23 2009 263 269
6. J. Liu, S. Liao, B. Diop-Frimpong, W. Chen, S. Goel, K. Naxerova, M. Ancukiewicz, Y. Boucher, R.K. Jain, and L. Xu TGF-beta blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma Proc. Natl. Acad. Sci. U. S. A. 109 2012 16618 16623
7. K. Cho, X. Wang, S. Nie, Z.G. Chen, and D.M. Shin Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 14 2008 1310 1316 (Pubitemid 351413909)
8. A.M. Gobin, J.J. Moon, and J.L. West EphrinA I-targeted nanoshells for photothermal ablation of prostate cancer cells Int. J. Nanomedicine 3 2008 351 358
9. H. Cabral, Y. Matsumoto, K. Mizuno, Q. Chen, M. Murakami, M. Kimura, Y. Terada, M.R. Kano, K. Miyazono, M. Uesaka, N. Nishiyama, and K. Kataoka Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size Nat. Nanotechnol. 6 2011 815 823
10. B. Diop-Frimpong, V.P. Chauhan, S. Krane, Y. Boucher, and R.K. Jain Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors Proc. Natl. Acad. Sci. U. S. A. 108 2011 2909 2914
11. R.K. Jain, and T. Stylianopoulos Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 7 2010 653 664
12. M.A. Shields, S. Dangi-Garimella, A.J. Redig, and H.G. Munshi Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression Biochem. J. 441 2012 541 552
13. D.R. Soto-Pantoja, J. Menon, P.E. Gallagher, and E.A. Tallant Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor Mol. Cancer Ther. 8 2009 1676 1683
14. T. Sethi, R.C. Rintoul, S.M. Moore, A.C. MacKinnon, D. Salter, C. Choo, E.R. Chilvers, I. Dransfield, S.C. Donnelly, R. Strieter, and C. Haslett Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo Nat. Med. 5 1999 662 668 (Pubitemid 29289430)
15. K.L. Cook, L.J. Metheny-Barlow, E.A. Tallant, and P.E. Gallagher Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors Cancer Res. 70 2010 8319 8328
16. G.J. Prud'homme Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations Lab. Invest. 87 2007 1077 1091
17. B. Kaminska, A. Wesolowska, and M. Danilkiewicz TGF beta signalling and its role in tumour pathogenesis Acta Biochim. Pol. 52 2005 329 337 (Pubitemid 41133768)
18. A.K. Reka, H. Kurapati, V.R. Narala, G. Bommer, J. Chen, T.J. Standiford, and V.G. Keshamouni Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition Mol. Cancer Ther. 9 2010 3221 3232
19. D.M. Ray, P.H. Myers, J.T. Painter, M.J. Hoenerhoff, K. Olden, and J.D. Roberts Inhibition of transforming growth factor-beta-activated kinase-1 blocks cancer cell adhesion, invasion, and metastasis Br. J. Cancer 107 2012 129 136
20. T. Imamura, A. Hikita, and Y. Inoue The roles of TGF-beta signaling in carcinogenesis and breast cancer metastasis Breast Cancer 19 2012 118 124
21. M.R. Kano, Y. Bae, C. Iwata, Y. Morishita, M. Yashiro, M. Oka, T. Fujii, A. Komuro, K. Kiyono, M. Kaminishi, K. Hirakawa, Y. Ouchi, N. Nishiyama, K. Kataoka, and K. Miyazono Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling Proc. Natl. Acad. Sci. U. S. A. 104 2007 3460 3465 (Pubitemid 46364181)
22. C.H. Lee, H.D. Kim, S.M. Shin, and S.G. Kim A novel mechanism of PPARgamma regulation of TGFbeta1: implication in cancer biology PPAR Res. 2008 2008 762398
23. Y. Maejima, H. Okada, G. Haraguchi, Y. Onai, H. Kosuge, J. Suzuki, and M. Isobe Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma Lab. Investig. 91 2011 932 944
24. S.C. Benson, H.A. Pershadsingh, C.I. Ho, A. Chittiboyina, P. Desai, M. Pravenec, N. Qi, J. Wang, M.A. Avery, and T.W. Kurtz Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity Hypertension 43 2004 993 1002 (Pubitemid 38579904)
25. K. Funao, M. Matsuyama, Y. Kawahito, H. Sano, J. Chargui, J.L. Touraine, T. Nakatani, and R. Yoshimura Telmisartan as a peroxisome proliferator-activated receptor-gamma ligand is a new target in the treatment of human renal cell carcinoma Mol. Med. Report 2 2009 193 198
26. A.P. Lakshmanan, K. Watanabe, R.A. Thandavarayan, F.R. Sari, M. Harima, V.V. Giridharan, V. Soetikno, M. Kodama, and Y. Aizawa Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-gamma agonist action Free Radic. Res. 45 2011 575 584
27. A. Geirsson, M. Singh, R. Ali, H. Abbas, W. Li, J.A. Sanchez, S. Hashim, and G. Tellides Modulation of transforming growth factor-beta signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers Circulation 126 2012 S189 S197
28. Y. Chen, Q. Luo, Z. Xiong, W. Liang, and L. Chen Telmisartan counteracts TGF-beta1 induced epithelial-to-mesenchymal transition via PPAR-gamma in human proximal tubule epithelial cells Int. J. Clin. Exp. Pathol. 5 2012 522 529
29. D. Gao, N. Ning, G. Hao, and X. Niu Pioglitazone attenuates vascular fibrosis in spontaneously hypertensive rats PPAR Res. 2012 2012 856426
30. B. Kociecka, A. Surazynski, W. Miltyk, and J. Palka The effect of Telmisartan on collagen biosynthesis depends on the status of estrogen activation in breast cancer cells Eur. J. Pharmacol. 628 2010 51 56
31. S. Rodrigues-Ferreira, M. Abdelkarim, P. Dillenburg-Pilla, A.C. Luissint, A. di-Tommaso, F. Deshayes, C.L. Pontes, A. Molina, N. Cagnard, F. Letourneur, M. Morel, R.I. Reis, D.E. Casarini, B. Terris, P.O. Couraud, C.M. Costa-Neto, M. Di Benedetto, and C. Nahmias Angiotensin II facilitates breast cancer cell migration and metastasis PLoS One 7 2012 e35667
32. P.E. Gallagher, K. Cook, D. Soto-Pantoja, J. Menon, and E.A. Tallant Angiotensin peptides and lung cancer Curr. Cancer Drug Targets 11 2011 394 404
33. B. Krishnan, F.M. Torti, P.E. Gallagher, and E.A. Tallant Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1 Prostate 73 2013 60 70
34. J. Menon, D.R. Soto-Pantoja, M.F. Callahan, J.M. Cline, C.M. Ferrario, E.A. Tallant, and P.E. Gallagher Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2 Cancer Res. 67 2007 2809 2815 (Pubitemid 46548970)
35. A.J. George, W.G. Thomas, and R.D. Hannan The renin-angiotensin system and cancer: old dog, new tricks Nat. Rev. Cancer 10 2010 745 759
36. D.R. Rhodes, B. Ateeq, Q. Cao, S.A. Tomlins, R. Mehra, B. Laxman, S. Kalyana-Sundaram, R.J. Lonigro, B.E. Helgeson, M.S. Bhojani, A. Rehemtulla, C.G. Kleer, D.F. Hayes, P.C. Lucas, S. Varambally, and A.M. Chinnaiyan AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist Proc. Natl. Acad. Sci. U. S. A. 106 2009 10284 10289
37. T. Kosaka, A. Miyajima, E. Takayama, E. Kikuchi, J. Nakashima, T. Ohigashi, T. Asano, M. Sakamoto, H. Okita, M. Murai, and M. Hayakawa Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer Prostate 67 2007 41 49 (Pubitemid 46013466)
38. D. Donovan, J.H. Harmey, D. Toomey, D.H. Osborne, H.P. Redmond, and D.J. Bouchier-Hayes TGF beta-1 regulation of VEGF production by breast cancer cells Ann. Surg. Oncol. 4 1997 621 627 (Pubitemid 127725489)
39. B. Krishnan, T.L. Smith, P. Dubey, M.E. Zapadka, F.M. Torti, M.C. Willingham, E.A. Tallant, and P.E. Gallagher Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis Prostate 73 2013 71 82
40. C. Doi, N. Egashira, A. Kawabata, D.K. Maurya, N. Ohta, D. Uppalapati, R. Ayuzawa, L. Pickel, Y. Isayama, D. Troyer, S. Takekoshi, and M. Tamura Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice BMC Cancer 10 2010 67
41. L. Pickel, T. Matsuzuka, C. Doi, R. Ayuzawa, D.K. Maurya, S.X. Xie, C. Berkland, and M. Tamura Overexpression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells Cancer Biol. Ther. 9 2010
42. S.A. Arnold, L.B. Rivera, J.G. Carbon, J.E. Toombs, C.L. Chang, A.D. Bradshaw, and R.A. Brekken Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFbeta activation PLoS One 7 2012 e31384
43. N. Ichite, M. Chougule, A.R. Patel, T. Jackson, S. Safe, and M. Singh Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer Mol. Cancer Ther. 9 2010 3003 3014
44. R. Navab, D. Strumpf, B. Bandarchi, C.Q. Zhu, M. Pintilie, V.R. Ramnarine, E. Ibrahimov, N. Radulovich, L. Leung, M. Barczyk, D. Panchal, C. To, J.J. Yun, S. Der, F.A. Shepherd, I. Jurisica, and M.S. Tsao Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer Proc. Natl. Acad. Sci. U. S. A. 108 2011 7160 7165
45. S. Haubeiss, J.O. Schmid, T.E. Murdter, M. Sonnenberg, G. Friedel, H. van der Kuip, and W.E. Aulitzky Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts Mol. Cancer 9 2010 168
46. V.P. Chauhan, Z. Popovic, O. Chen, J. Cui, D. Fukumura, M.G. Bawendi, and R.K. Jain Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration Angew. Chem. Int. Ed. Engl. 50 2011 11417 11420
47. T.D. McKee, P. Grandi, W. Mok, G. Alexandrakis, N. Insin, J.P. Zimmer, M.G. Bawendi, Y. Boucher, X.O. Breakefield, and R.K. Jain Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector Cancer Res. 66 2006 2509 2513
48. T. Minowa, K. Kawano, H. Kuribayashi, K. Shiraishi, T. Sugino, Y. Hattori, M. Yokoyama, and Y. Maitani Increase in tumour permeability following TGF-beta type I receptor-inhibitor treatment observed by dynamic contrast-enhanced MRI Br. J. Cancer 101 2009 1884 1890
49. H. Ishiguro, Y. Ishiguro, Y. Kubota, and H. Uemura Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action Prostate 67 2007 924 932 (Pubitemid 46828926)
50. A.K. Reka, M.T. Goswami, R. Krishnapuram, T.J. Standiford, and V.G. Keshamouni Molecular cross-regulation between PPAR-gamma and other signaling pathways: implications for lung cancer therapy Lung Cancer 72 2011 154 159
51. I. Sipahi, S.M. Debanne, D.Y. Rowland, D.I. Simon, and J.C. Fang Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials Lancet Oncol. 11 2010 627 636
52. C.A. Znati, M. Rosenstein, T.D. McKee, E. Brown, D. Turner, W.D. Bloomer, S. Watkins, R.K. Jain, and Y. Boucher Irradiation reduces interstitial fluid transport and increases the collagen content in tumors Clin. Cancer Res. 9 2003 5508 5513 (Pubitemid 37499469)